Twitxy Saved

Aaron Kesselheim

@akesselheim

Professor of Medicine, Harvard Medical School; Director, Program On Regulation, Therapeutics, And Law (PORTAL), Brigham and Women's Hospital
Boston portalresearch.org Joined February 2009
257 Following 4.7K Followers 825 Posts

Latest posts 5

Aaron Kesselheim @akesselheim
Happy to have the opportunity to hype this huge new piece that happened to hit on this holiday: led by @bnrome, a viewpoint on issues relating to the emergence (hooray!) of new biosimilar Humira: pubmed.ncbi.nlm.nih.gov/37026489/
pubmed.ncbi.nlm.nih.gov Biosimilar Competition for Humira Is Here: Signs of Hope Despite Early Hiccups - PubMed Biosimilar Competition for Humira Is Here: Signs of Hope Despite Early Hiccups
0 replies 4 reposts 16 likes 3.5K views View on X
Aaron Kesselheim @akesselheim
New entry in the @NEJM Fundamentals of Health Law Series! Consolidation and competition in the health care sector -- and implications for patients and pricing; from Jaime King. Collect them all!: nejm.org/doi/full/10.10…
www.nejm.org On Consolidation and Competition — The Trials and Triumphs of Health Care Antitrust Law | NEJM Consolidation in health care has occurred by means of horizontal, vertical, and cross-market transactions as well as private-equity investment. In recent years, such moves have gone largely unchecked.
Next in our @NEJM Fundamentals of Health Law series: a focus on fraud/abuse and COI rules with Prof Zack Buck from Univ of Tennessee: nejm.org/doi/pdf/10.105…
View quoted post on X